证券记录 · 已归档季度
BHVN
Biohaven Ltd. · Healthcare · Biotechnology
19被追踪持有人
+1Δ持有人
32.20M持有股份
$483.28M报告持仓市值
+2新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +5.6% ·
股份流向 -9.4% ·
净新建仓位 0.0%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +2 | 76.78M | $1.14B | +6 | −4 |
| Q1 2026 | 95 | 0 | 88.72M | $750.66M | +4 | −4 |
| Q4 2025 | 95 | -1 | 70.26M | $793.21M | +1 | −2 |
| Q3 2025 | 19 | +1 | 32.20M | $483.28M | +2 | −2 |
| Q2 2025 | 16 | -1 | 31.66M | $446.69M | — | −1 |
| Q1 2025 | 14 | -1 | 13.40M | $322.18M | — | −1 |
| Q4 2024 | 15 | +1 | 14.58M | $544.70M | +1 | — |
| Q3 2024 | 13 | 0 | 12.61M | $630.01M | — | — |
| Q2 2024 | 13 | — | 11.04M | $383.32M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 7.87M | +4.5% | $118.20M | 0.0% | ▲ Add | 2 | SEC ↗ ×15 |
| 2 | State Street Global Advisors ✦ (被动) | 4.26M | +20.4% | $63.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 2.88M | -68.9% | $43.16M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 4 | JPMorgan Chase ✦ | 2.67M | — | $40.09M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 5 | Fidelity (FMR) ✦ | 2.43M | +45.8% | $36.43M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 6 | Geode Capital Management ✦ (被动) | 2.06M | +1.4% | $30.93M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | T. Rowe Price ✦ | 2.01M | -36.6% | $30.16M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 8 | Goldman Sachs Group ✦ | 1.58M | — | $23.69M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | D. E. Shaw & Co. ✦ | 1.27M | +144.2% | $19.01M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Adage Capital Partners ✦ | 1.26M | +100.0% | $18.91M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 997.79K | +208.6% | $14.98M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 968.15K | -40.5% | $14.53M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 799.60K | +986.0% | $12.00M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 545.82K | — | $8.19M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 15 | Capital World Investors ✦ | 250.00K | 0.0% | $3.75M | 0.0% | Held | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 213.27K | +173.9% | $3.20M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 17 | Point72 Asset Management ✦ | 81.00K | 新增 | $1.22M | 0.0% | New | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 39.80K | +6.2% | $597,323 | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 19 | Bridgewater Associates ✦ | 20.06K | 新增 | $301,101 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $1.22M | 0.0% |
| Bridgewater Associates | $301,101 | 0.0% |
已清仓
| Norges Bank | $12.74M | 曾为 0.0% |
| Marshall Wace | $372,208 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 51.20K 股份, $433 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据